Skip to main content

HDA board elects Cardinal Health’s Giacomin chairman


ARLINGTON, Va. — Cardinal Health’s pharmaceutical segment CEO Jon Giacomin has a new role on the board of directors for the Healthcare Distribution Alliance (HDA). HDA’s board elected Giacomin to the position of chairman at its annual board and membership meeting and announced the change Monday. 


Giacomin had served as the board’s vice-chairman since November 2014, and takes over the chairmanship from Dakota Drug president and CEO Ted Scherr, who was elected to the position in September 2014. Scherr will remain on HDA’s executive committee and the vice-chairmanship will be taken over by H.D. Smith Holding Co. chairman and CEO Henry Dale Smith, Jr., who was recently recognized with the Nexus Award for Lifetime Achievement. 


“During his two years as chairman, [Scherr] helped lead us through the launch of our new brand identity, the passage of S. 483 and an increased global presence, and leaves us well-positioned for the future.” HDA president and CEO John Gray said. “I look forward to working closely with Jon and Dale as they assume their new leadership positions. Together with our board of directors, we will continue to support the important work of our members based on our core values of collaboration and supply chain leadership.”   


HAD also announced new board and executive committee members. The new executive committee members are Burlington Drug Co. VP Maria Burns and Value Drug Co. president Greg Drew. New board members are Miami-Luken president and CEO Michael Faul; Smith Drug president Jeff Foreman; Mutual Wholesale Drug Co. CEO Hal Harrison; Seacoast Medical CEO David MacFarlane; and Keith Patek, Prodigy Health Supplier Corp.’s VP corporate strategy and development. 


This ad will auto-close in 10 seconds